Validated models for predicting skin penetration from different vehicles

European Journal of Pharmaceutical Sciences

Volumn 41, Issue 5, 2010, Pages 612-616

  Ghafourian, Taravat ^a   Samaras, Eleftherios G ^a   Brooks, James D ^b   Riviere, Jim E ^b  

^a MEDWAY SCHOOL OF PHARMACY   (United Kingdom)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

Formulation; Mixture; Penetration; Permeation; QSAR; Skin

Indexed keywords

4 NITROPHENOL; ATRAZINE; CAFFEINE; CHLORPYRIFOS; CODEINE; DRUG VEHICLE; FENTHION; NIMODIPINE; NONYLPHENOL; OCTANOL; PARATHION; PARATHION METHYL; PENTACHLOROPHENOL; PHENOL DERIVATIVE; PROPAZINE; SIMAZINE; SOLVENT; TESTOSTERONE; TRIAZINE;

ARTICLE; DRUG FORMULATION; DRUG SOLUBILITY; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; SKIN PENETRATION; SKIN PERMEABILITY; STATISTICAL MODEL; SWINE; VALIDATION STUDY;

ADMINISTRATION, CUTANEOUS; ANIMALS; CAFFEINE; CODEINE; COMPLEX MIXTURES; MODELS, CHEMICAL; MODELS, STATISTICAL; MOLECULAR STRUCTURE; OCTANOLS; PERMEABILITY; PHARMACEUTICAL VEHICLES; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; SKIN; SKIN ABSORPTION; SWINE; TESTOSTERONE;

EID: 78349309848     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejps.2010.08.014     Document Type: Article

References (35)

1. Barry B.W. Transdermal drug delivery. Aulton's Pharmaceutics, The Design and Manufacture of Medicines 2007, 580-585. Elsevier, Churchill Livingstone. third ed. M.E. Aulton (Ed.).
2. CambridgeSoft ChemBioFinder (accessed 09.09). http://www.cambridgesoft.com/databases.
3. Chu K.A., Yalkowsky S.H. An interesting relationship between drug absorption and melting point. Int. J. Pharm. 2009, 373:24-40.
4. Cilurzo F., Alberti E., Minghetti P., Gennari C.G.M., Casiraghi A., Montanari L. Effect of drug chirality on the skin permeability of ibuprofen. Int. J. Pharm. 2010, 386:71-76.
5. Dias M., Hadgraft J., Lane M.E. Influence of membrane-solvent-solute interactions on solute permeation in skin. Int. J. Pharm. 2007, 340:65-70.
6. Diudea M.V., Gutman I. Wiener-type topological indices. Croat. Chem. Acta 1998, 71:21-51.
7. Elias P.M. Epidermal lipids, barrier function and desquamation. J. Invest. Dermatol. 1983, 80:44-49.
8. El Tayar N., Tsai R.-S., Testa B., Carrupt P.-A., Hansch C., Leo A. Percutaneous penetration of drugs: a quantitative structure-permeability relationship study. J. Pharm. Sci. 1991, 80:744-749.
9. Fedors R.F. Methods for estimating both solubility parameters and molar volumes of liquids. Polym. Eng. Sci. 1974, 14:47-154.
10. Flynn G.L. Physicochemical determinants of skin absorption. Principles of Route to Route Extrapolitation for Risk Assessment Extraction for Skin Assessment 1990, 93-127. Elsevier, New York. T.R. Gerrity, C.J. Henry (Eds.).
11. Ghafourian T., Zandasrar P., Hamishekar H., Nokhodchi A. The effect of penetration enhancers on drug delivery through skin: a QSAR study. J. Control. Release 2004, 99:113-125.
12. Ghafourian T., Samaras E.G., Brooks J.D., Riviere J.E. Modelling the effect of mixture components on permeation through skin. Int. J. Pharm. 2010, 398:28-32.
13. Hansen C.M. The three dimensional solubility parameter-key to paint component affinities. I. Solvents, plasticizers, polymers and resins. J. Paint Technol. 1967, 39:104-117.
14. Kai T., Mak V.H.W., Potts R.O., Guy R.H. Mechanisms of percutaneous penetration enhancement: effect of n-alkanols on the permeability barrier of hairless mouse skin. J. Control. Release 1990, 12:103-112.
15. Krishnaiah Y.S.R., Bhaskar P., Satyanarayana V. Penetration-enhancing effect of ethanol-water solvent system and ethanolic solution of carvone on transdermal permeability of nimodipine from HPMC gel across rat abdominal skin. Pharm. Dev. Technol. 2004, 9:63-74.
16. Krishnaiah Y.S.R., Satyanarayana V., Karthikeyan R.S. Effect of the solvent system on the in vitro permeability of nicardipine hydrochloride through excised rat epidermis. J. Pharm. Pharmaceut. Sci. 2002, 5:123-130.
17. Liron Z., Cohen S. Percutaneous absorption of alkanoic acids. II. Application of regular solution theory. J. Pharm. Sci. 1984, 73:538-542.
18. Ma Q.H., Hao X.Z., Zhou H.F., Gu N. Effect of surfactants on preparation and skin penetration of tea polyphenols liposomes. IEEE/ICME International Conference on Complex Medical Engineering, vols. 1-4 2007, 209-212.
19. Monene L.M., Goosen C., Breytenbach J.C., Hadgraft J., du Plessis J. Percutaneous absorption of cyclizine and its alkyl analogues. Eur. J. Pharm. Sci. 2005, 24:239-244.
20. Moss P.G., Dearden J.C., Patel H., Cronin M.T.D. Quantitative structure-permeability relationships (QSPRs) for percutaneous absorption. Toxicol. In Vitro 2002, 16:299-317.
21. Pedretti A., Villa L., Vistoli G. Modeling of binding modes and inhibition mechanism of some natural ligands of farnesyl transferase using molecular docking. J. Med. Chem. 2002, 45:1460-1465.
22. Pugh W.J., Roberts M.S., Hadgraft J. Epidermal permeability-penetrant structure relationships. 3. The effect of hydrogen bonding interactions and molecular size on diffusion across the stratum corneum. Int. J. Pharm. 1996, 138:149-165.
23. Raykar P.V., Fung M.C., Anderson B.D. The role of protein and lipid domains in the uptake of solutes by human stratum corneum. Pharm. Res. 1988, 5:140-150.
24. Riviere J.E., Brooks J.D. Chemical Mixture Absorption Dataset 2010, http://www.lib.ncsu.edu/resolver/1840.2/2297.
25. Riviere J.E., Brooks J.D. Prediction of dermal absorption from complex chemical mixtures: incorporation of vehicle effects and interactions into a QSPR framework. SAR QSAR Environ. Res. 2007, 18:31-44.
26. Riviere J.E., Brooks J.D. Predicting skin permeability from complex chemical mixtures. Toxicol. Appl. Pharmacol. 2005, 208:99-100.
27. Roberts M., Cross S., Pellet M. Skin transport. Dermatological and Transdermal Formulations 2002, 89-195. Marcel Dekker, New York. K.A. Walters (Ed.).
28. Rosado C., Cross S.E., Pugh W.J., Roberts M.S., Hadgraft J. Effect of vehicle pretreatment on the flux, retention, and diffusion of topically applied penetrants in vitro. Pharm. Res. 2003, 20:1502-1507.
29. Roy S.D., Flynn G.L. Transdermal delivery of narcotic analgesics: comparative permeabilities of narcotic analgesics through human cadaver skin. Pharm. Res. 1989, 6:825-832.
30. Shah V.P. Skin penetration enhancers: scientific perspectives. Drug Permeation Enhancement Theory and Applications 1994, 19-24. Marcel Decker, New York. D.S. Hsieh (Ed.).
31. Slovokhotov Y.L., Batsanov A.S., Howard J.A.K. Molecular van der Waals symmetry affecting bulk properties of condensed phases: melting and boiling points. Struct. Chem. 2007, 18:477-491.
32. Syracuse Research Corporation SRC PhysProp Database 2009, (retrieved 20.09.09). http://www.syrres.com/what-we-do/databaseforms.aspx?id=386.
33. Williams A.C., Barry B.W. Penetration enhancers. Adv. Drug Deliv. Rev. 2004, 56:603-618.
34. Wilschut A., Berge W.F., Robinson P.J., McKone T.E. Estimating skin permeation. The validation of five mathematical skin permeation models. Chemosphere 1995, 30:1275-1296.
35. Zinke S., Gerner I., Schlede E. Evaluation of a rule base for identifying contact allergens by using a regulatory database: comparison of data on chemicals notified in the European Union with with 'structural alerts' used in the DEREK expert system. Altern. Lab. Anim. 2002, 30:285-298.